Abstract:Objective: Human papillomaviruses are closely associated with human cervical cancer, especially HPV types 16 and 18. At present, HPV can not be produced in large quantity; it also has tumorgenicity and these properties of HPV have seriously hampered the development of HPV vaccine. HPV type 16 LI proteins can assembled into virus-like particles (VLP), which are morphologically identical to the nature virion. In order to develop the recombinant adenovirus vectors of HPV, we constructed a recombinant adenovirus shuttle plasmid pCA14 L1-E7C. Methods: Human papillomavirus type 16 LI open reading frame without terminator codon (TAA) (5559–7152) and E7C (682–855) were amplified using PCR. The L1 and E7C fragments were inserted into pGEM-T easy vectors by T-A strategy, named pTAL1 and pTAE7C. pTAL1 was cut with Hind III and BgIII, the pTAE7C with BamHI and ClaI. The L1 DNA fragment, E7C and pBluesscript SK were ligated together using T4 DNA ligase. pBSL1-E7C and pBSL1-E7C was digested with Hind III and Xhol. The L1-E7C fragment was inserted into adenovirus shuttle plasmids pCA14, named pCA14L1-E7C. DNA sequence results indicated that The L1-E7C DNA fragment can encode the HPV16L1-E7 fusion protein correctly. Results: The L1 and E7C DNA fragments were amplified by PCR and recombinant plasmid pTAL1, pTAE7C, pBSL1-E7C and pCA14L1-E7C were constructed correctly. The pCA14L1-E7C can be used in the further research work, cotransfected the 293 cell with the parent adenovirus pBHG10. Conclusion: Our results indicated that we have constructed a HPV16L1-E7 fusion DNA fragments and the adenovirus shuttle plasmids pCAL1-E7C for the further research.

Construction and Identification of Recombinant Modified Vaccine Virus Ankara for Expression of Late Protein L1 Gene of Human Papillomavirus Type 16

Construction, Expression, Purification and Identification of Chimeric HPV16 E7-L1 Virus Like Particles

Expression of human papillomavirus type16 late gene (L1) in prokaryotic cells and its immune effict observation

Construction and Expression of Eukaryotic Expression Plasmid with L1 Gene of Human Papillomavirus Type 16

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

[Computer-aided-designing and eukaryotic expression of recombinant HPV 16 vcaccine].

Construction of a Recombinant Adenovirus Vector of Human Papillomavirus Type 16 L1_E7C

Construction of an Attenuated Recombinant Adenoviral Vaccine of Human Papillomavirus Type 16 L1-E7 and Expression of the Chimeric Virus-Like Particles in 293 Cells

Expression of Genetically Modified Human Papillomavirus Type 58 L1 Gene and Production of Antisera Against Resultant VLP

[Cloning and Expressing of Human Papillomavirus 16 E7C Subgene].

[Construction and Immunological Evaluation of Recombinant Adenovirus Containing Codon-Modified HPV 16 L1 Gene].

The construction of HPV16-L1 recombinant plasmid and its expression in mammalian cells

Construction of a Chimeric Gene of Human Papillomavirus Type 16 L1-E7 and Immunogenicity of Expressed Fusion Protein

Production of human papillomavirus type 16 virus-like particles and its immunogenicity]

[Prokaryotic Expression of HPV 16 L1 Gene and Identification of Its Immune Activity].

Construction and Expression of Effective VLPs Gene Transfer Vectors Composed of Recombinant Protein of Human Papillomavirus 16 L1 for Targeting Gd-B Cell of IgA Nephropathy

Construction and identification of drosophila expression vector of protein L1 gene of human papillomavirus type 18

[Construction of Codon-Optimized HPV16 Capsid Genes in the Eukaryotic Co-Expression Vector and Transfection of Cells].

[Preliminary Study of HPV16 L1/E6-E7 Chimeric Recombinant DNA Vaccine Plasmid Construction and Expression in CHO Cell].

The construction of chimerical DNA vaccine plasmid of HPV-6/11 L1/E6 and HPV-6/11 L1/E7

Functional HPV16L1 VLP can be efficiently expressed by His-tag baculovirus expression system